Mohammad Sheibani

4 ta ish

Iran University of Medical Sciences

1. Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy

   Ashot Avagimyan, Mohammad Sheibani, Nana Pogosova +8

   Maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.282558

2. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

   Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11

   MaqolaOAOchiq kirishChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 iqtibos

   ABIABI:AkademIndex/2023.article.001614

3. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

   Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

   MaqolaOAOchiq kirishDiabetes Treatment and ManagementInnovative medicine of Kuban20241 iqtibos

   ABIABI:AkademIndex/2024.article.001048

4. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)

   Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

   MaqolaOAOchiq kirishDiabetes Treatment and ManagementInnovative medicine of Kuban20250 iqtibos

   ABIABI:AkademIndex/2025.article.002727